Geftinat Tablets

Geftinat Tablets Specification

Indication
Non-small cell lung cancer (NSCLC)

Dosage Form
Geftinat Tablets

Origin
India

Salt Composition
Gefitinib 250 mg

Enzyme Types
Geftinat Tablets

Feature
Targeted EGFR inhibitor therapy

Ingredients
Gefitinib

Application
Oral anti-cancer therapy

Physical Color/Texture
Film-coated tablet, light brown

Storage Instructions
Cool & Dry Place

Shelf Life
24 months

Packing Size
30 tablets per bottle

Strength
250 mg

Administration Route
Oral

Product Brand Name
Geftinat

Storage Condition
Dry, cool place, tightly closed

ATC Classification
L01EB01

Packaging Type
Bottle

Prescription Status
Prescription only

Geftinat Tablets Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
100 Packs Per Day

Delivery Time
2 Days

About Geftinat Tablets

Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Targeted Cancer Therapy

Geftinat Tablets are designed as a targeted oral treatment for patients diagnosed with non-small cell lung cancer (NSCLC). By inhibiting the EGFR pathway, they aim to slow or stop the growth of cancer cells. This makes Geftinat a valuable therapeutic option for individuals whose tumors demonstrate EGFR mutations, with potential benefits over conventional chemotherapy.

Prescription and Administration

This medication is strictly prescription-only, ensuring that only patients under proper medical supervision can access it. The tablets are to be taken orally, with the specific dose and duration directed by an oncologist. Following professional advice is crucial for maximizing therapeutic outcomes and managing any possible adverse reactions.

Safe Handling and Storage

To preserve the effectiveness and integrity of Geftinat Tablets, keep the bottle tightly closed and store it in a cool, dry place away from moisture and direct sunlight. Following these storage guidelines helps ensure the product remains stable for up to 24 months from the date of manufacture.

FAQ's of Geftinat Tablets:

Q: How should Geftinat Tablets be taken for best results?

A: Geftinat Tablets must be taken orally, usually once daily as prescribed by your doctor. It is important to swallow the tablet whole with water, not to chew or crush it, and to follow the prescribed schedule and dosage for optimal effectiveness.

Q: What is the therapeutic benefit of Geftinat Tablets in cancer treatment?

A: Geftinat Tablets offer targeted therapy by inhibiting the epidermal growth factor receptor (EGFR), which may help slow the growth of certain types of non-small cell lung cancer (NSCLC), particularly in patients with specific EGFR mutations.

Q: When should I take Geftinat Tablets during the day?

A: It is recommended to take Geftinat Tablets at the same time each day to maintain consistent blood levels. Your doctor will provide further guidance on the timing that best suits your treatment plan.

Q: Where should I store my bottle of Geftinat Tablets?

A: Store the bottle in a cool and dry place, away from direct light and moisture. Keep the lid tightly closed and ensure the medication is out of reach of children and unauthorized persons.

Q: What is the process if a dose is missed?

A: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double up to make up for a missed dose. Always consult your doctor for further advice if you are unsure.

Q: Who can prescribe Geftinat Tablets and why is a prescription necessary?

A: Geftinat Tablets can only be prescribed by a qualified healthcare provider, usually an oncologist. A prescription is required to ensure the patient is monitored, the medication is used safely, and the correct indication-such as EGFR-positive NSCLC-is met.

Tell us about your requirement